{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:34:49Z","timestamp":1775014489884,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":3942,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1074\/mcp.m900285-mcp200","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T20:12:48Z","timestamp":1249330368000},"page":"2796-2808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":204,"title":["Global Effects of Kinase Inhibitors on Signaling Networks Revealed by Quantitative Phosphoproteomics"],"prefix":"10.1016","volume":"8","author":[{"given":"Cuiping","family":"Pan","sequence":"first","affiliation":[]},{"given":"Jesper V.","family":"Olsen","sequence":"additional","affiliation":[]},{"given":"Henrik","family":"Daub","sequence":"additional","affiliation":[]},{"given":"Matthias","family":"Mann","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1074\/mcp.M900285-MCP200_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1634\/theoncologist.6-3-233","article-title":"STI571: targeting BCR-ABL as therapy for CML","volume":"6","author":"Mauro","year":"2001","journal-title":"Oncologist"},{"key":"10.1074\/mcp.M900285-MCP200_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-200060001-00004","article-title":"ZD1839 (\u2018Iressa\u2018) as an anticancer agent","volume":"60","author":"Baselga","year":"2000","journal-title":"Drugs"},{"key":"10.1074\/mcp.M900285-MCP200_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrd773","article-title":"Protein kinases\u2014the major drug targets of the twenty-first century?","volume":"1","author":"Cohen","year":"2002","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/mcp.M900285-MCP200_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/092986708783503212","article-title":"From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage","volume":"15","author":"Petrelli","year":"2008","journal-title":"Curr. Med. Chem"},{"key":"10.1074\/mcp.M900285-MCP200_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.chembiol.2005.04.011","article-title":"Features of selective kinase inhibitors","volume":"12","author":"Knight","year":"2005","journal-title":"Chem. Biol"},{"key":"10.1074\/mcp.M900285-MCP200_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20021535","article-title":"The specificities of protein kinase inhibitors: an update","volume":"371","author":"Bain","year":"2003","journal-title":"Biochem. J"},{"key":"10.1074\/mcp.M900285-MCP200_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J"},{"key":"10.1074\/mcp.M900285-MCP200_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M900285-MCP200_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M900285-MCP200_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.chembiol.2004.02.001","article-title":"A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors","volume":"11","author":"Becker","year":"2004","journal-title":"Chem. Biol"},{"key":"10.1074\/mcp.M900285-MCP200_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbapap.2005.07.028","article-title":"Characterisation of kinase-selective inhibitors by chemical proteomics","volume":"1754","author":"Daub","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/mcp.M900285-MCP200_bib12","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nbt1328","article-title":"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors","volume":"25","author":"Bantscheff","year":"2007","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M900285-MCP200_bib13","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med"},{"key":"10.1074\/mcp.M900285-MCP200_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd839","article-title":"Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug","volume":"1","author":"Capdeville","year":"2002","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/mcp.M900285-MCP200_bib15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"key":"10.1074\/mcp.M900285-MCP200_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.1142946","article-title":"Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies","volume":"318","author":"Stommel","year":"2007","journal-title":"Science"},{"key":"10.1074\/mcp.M900285-MCP200_bib17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.drudis.2006.07.003","article-title":"Cytomics as a new potential for drug discovery","volume":"11","author":"Valet","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1074\/mcp.M900285-MCP200_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/cb600321j","article-title":"Small-molecule screening: advances in microarraying and cell-imaging technologies","volume":"2","author":"Nicholson","year":"2007","journal-title":"ACS Chem. Biol"},{"key":"10.1074\/mcp.M900285-MCP200_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrd2008","article-title":"Cellular imaging in drug discovery","volume":"5","author":"Lang","year":"2006","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/mcp.M900285-MCP200_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nchembio.2007.59","article-title":"High-content single-cell drug screening with phosphospecific flow cytometry","volume":"4","author":"Krutzik","year":"2008","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/mcp.M900285-MCP200_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1074\/mcp.M200025-MCP200","article-title":"Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics","volume":"1","author":"Ong","year":"2002","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrm2067","article-title":"Functional and quantitative proteomics using SILAC","volume":"7","author":"Mann","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/mcp.M900285-MCP200_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cell.2007.07.032","article-title":"Is proteomics the new genomics?","volume":"130","author":"Cox","year":"2007","journal-title":"Cell"},{"key":"10.1074\/mcp.M900285-MCP200_bib24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.molcel.2008.07.018","article-title":"Combined use of RNAi and quantitative proteomics to study gene function in Drosophila","volume":"31","author":"Bonaldi","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1074\/mcp.M900285-MCP200_bib25","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/gb-2006-7-6-r50","article-title":"Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system","volume":"7","author":"de Godoy","year":"2006","journal-title":"Genome Biol"},{"key":"10.1074\/mcp.M900285-MCP200_bib26","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1073\/pnas.0603948103","article-title":"Phosphoproteomic analysis of Her2\/neu signaling and inhibition","volume":"103","author":"Bose","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M900285-MCP200_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nbt0302-301","article-title":"Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae","volume":"20","author":"Ficarro","year":"2002","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M900285-MCP200_bib28","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/ac0498617","article-title":"Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS\/MS and titanium oxide precolumns","volume":"76","author":"Pinkse","year":"2004","journal-title":"Anal. Chem"},{"key":"10.1074\/mcp.M900285-MCP200_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1074\/mcp.M400219-MCP200","article-title":"Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway","volume":"4","author":"Gruhler","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1074\/mcp.T500007-MCP200","article-title":"Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns","volume":"4","author":"Larsen","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2006.09.026","article-title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks","volume":"127","author":"Olsen","year":"2006","journal-title":"Cell"},{"key":"10.1074\/mcp.M900285-MCP200_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jprot.2008.01.004","article-title":"Identification of dominant signaling pathways from proteomics expression data","volume":"71","author":"Zubarev","year":"2008","journal-title":"J. Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.molcel.2008.09.001","article-title":"Phosphoproteomics: unraveling the signaling web","volume":"31","author":"Huang","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1074\/mcp.M900285-MCP200_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pharmtox.011008.145606","article-title":"Global and site-specific quantitative phosphoproteomics: principles and applications","volume":"49","author":"Macek","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"10.1074\/mcp.M900285-MCP200_bib35","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/mcp.M900285-MCP200_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1634\/theoncologist.2001-0230","article-title":"The oncologic four-minute mile","volume":"6","author":"Chabner","year":"2001","journal-title":"Oncologist"},{"key":"10.1074\/mcp.M900285-MCP200_bib37","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.clinthera.2007.11.005","article-title":"Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"29","author":"Steinberg","year":"2007","journal-title":"Clin. Ther"},{"key":"10.1074\/mcp.M900285-MCP200_bib38","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-05-0259","article-title":"In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants","volume":"65","author":"O'Hare","year":"2005","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M900285-MCP200_bib39","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J. Med. Chem"},{"key":"10.1074\/mcp.M900285-MCP200_bib40","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1182\/blood-2005-08-3399","article-title":"A common phosphotyrosine signature for the Bcr-Abl kinase","volume":"107","author":"Goss","year":"2006","journal-title":"Blood"},{"key":"10.1074\/mcp.M900285-MCP200_bib41","doi-asserted-by":"crossref","first-page":"13283","DOI":"10.1073\/pnas.0702654104","article-title":"The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib","volume":"104","author":"Hantschel","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M900285-MCP200_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1074\/mcp.M800258-MCP200","article-title":"Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type specific functions","volume":"8","author":"Pan","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib43","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1074\/mcp.M600464-MCP200","article-title":"The serine\/threonine\/tyrosine phosphoproteome of the model bacterium Bacillus subtilis","volume":"6","author":"Macek","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib44","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1002\/pmic.200800105","article-title":"Quantitative phosphoproteome analysis of a mouse liver cell line reveals specificity of phosphatase inhibitors","volume":"8","author":"Pan","year":"2008","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib45","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1074\/mcp.T400003-MCP200","article-title":"Trypsin cleaves exclusively C-terminal to arginine and lysine residues","volume":"3","author":"Olsen","year":"2004","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib46","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1074\/mcp.T500030-MCP200","article-title":"Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap","volume":"4","author":"Olsen","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib47","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1021\/ac0497104","article-title":"A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry","volume":"76","author":"Schroeder","year":"2004","journal-title":"Anal. Chem"},{"key":"10.1074\/mcp.M900285-MCP200_bib48","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M900285-MCP200_bib49","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1074\/mcp.M700460-MCP200","article-title":"Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins","volume":"7","author":"Graumann","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M900285-MCP200_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nsb0497-311","article-title":"A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket","volume":"4","author":"Tong","year":"1997","journal-title":"Nat. Struct. Biol"},{"key":"10.1074\/mcp.M900285-MCP200_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem. J"},{"key":"10.1074\/mcp.M900285-MCP200_bib52","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.embor.7400755","article-title":"MAPK signalling: ERK5 versus ERK1\/2","volume":"7","author":"Nishimoto","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1074\/mcp.M900285-MCP200_bib53","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"10.1074\/mcp.M900285-MCP200_bib54","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1074\/jbc.274.5.2893","article-title":"Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo","volume":"274","author":"Smith","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M900285-MCP200_bib55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.febslet.2004.07.031","article-title":"Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2","volume":"572","author":"Morton","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1074\/mcp.M900285-MCP200_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/02699050500284218","article-title":"The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions","volume":"24","author":"Yoon","year":"2006","journal-title":"Growth Factors"},{"key":"10.1074\/mcp.M900285-MCP200_bib57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jcp.21394","article-title":"Transcriptional profiling defines the roles of ERK and p38 kinases in epidermal keratinocytes","volume":"215","author":"Gazel","year":"2008","journal-title":"J. Cell. Physiol"},{"key":"10.1074\/mcp.M900285-MCP200_bib58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cellsig.2005.11.003","article-title":"Regulation of cellular functions by the ERK5 signalling pathway","volume":"18","author":"Wang","year":"2006","journal-title":"Cell. Signal"},{"key":"10.1074\/mcp.M900285-MCP200_bib59","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1073\/pnas.90.8.3216","article-title":"Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62","volume":"90","author":"Gupta","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M900285-MCP200_bib60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc2126","article-title":"Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia","volume":"7","author":"Weisberg","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/mcp.M900285-MCP200_bib61","first-page":"63","article-title":"FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis","volume":"1785","author":"Jagani","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/mcp.M900285-MCP200_bib62","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","article-title":"Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors","volume":"77","author":"Emanuel","year":"1991","journal-title":"Blood"},{"key":"10.1074\/mcp.M900285-MCP200_bib63","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","article-title":"BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death","volume":"83","author":"McGahon","year":"1994","journal-title":"Blood"},{"key":"10.1074\/mcp.M900285-MCP200_bib64","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/nar\/28.18.3442","article-title":"STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene","volume":"28","author":"Snel","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.M900285-MCP200_bib65","doi-asserted-by":"crossref","first-page":"D358","DOI":"10.1093\/nar\/gkl825","article-title":"STRING 7\u2014recent developments in the integration and prediction of protein interactions","volume":"35","author":"von Mering","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.M900285-MCP200_bib66","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1073\/pnas.0700058104","article-title":"Cell-cycle-dependent phosphorylation of the nuclear pore Nup107\u2013160 subcomplex","volume":"104","author":"Glavy","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M900285-MCP200_bib67","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1073\/pnas.0504952102","article-title":"Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases","volume":"102","author":"Carter","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620339232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620339232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M900285-MCP200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:54:59Z","timestamp":1761526499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620339232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1535947620339232"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m900285-mcp200","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global Effects of Kinase Inhibitors on Signaling Networks Revealed by Quantitative Phosphoproteomics","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M900285-MCP200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}